154 related articles for article (PubMed ID: 2468622)
1. Interaction of neuropeptides with human mast cells.
Church MK; Lowman MA; Robinson C; Holgate ST; Benyon RC
Int Arch Allergy Appl Immunol; 1989; 88(1-2):70-8. PubMed ID: 2468622
[TBL] [Abstract][Full Text] [Related]
2. Differential release of histamine and eicosanoids from human skin mast cells activated by IgE-dependent and non-immunological stimuli.
Benyon RC; Robinson C; Church MK
Br J Pharmacol; 1989 Jul; 97(3):898-904. PubMed ID: 2474353
[TBL] [Abstract][Full Text] [Related]
3. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils.
Columbo M; Horowitz EM; Botana LM; MacGlashan DW; Bochner BS; Gillis S; Zsebo KM; Galli SJ; Lichtenstein LM
J Immunol; 1992 Jul; 149(2):599-608. PubMed ID: 1378071
[TBL] [Abstract][Full Text] [Related]
4. General anaesthetics induce only histamine release selectively from human mast cells.
Stellato C; Casolaro V; Ciccarelli A; Mastronardi P; Mazzarella B; Marone G
Br J Anaesth; 1991 Dec; 67(6):751-8. PubMed ID: 1722691
[TBL] [Abstract][Full Text] [Related]
5. Characterization of neuropeptide-induced histamine release from human dispersed skin mast cells.
Lowman MA; Benyon RC; Church MK
Br J Pharmacol; 1988 Sep; 95(1):121-30. PubMed ID: 2464382
[TBL] [Abstract][Full Text] [Related]
6. Mast cells, neuropeptides and inflammation.
Church MK; Lowman MA; Rees PH; Benyon RC
Agents Actions; 1989 Apr; 27(1-2):8-16. PubMed ID: 2473641
[No Abstract] [Full Text] [Related]
7. Purification and characterization of human skin mast cells. Evidence for human mast cell heterogeneity.
Lawrence ID; Warner JA; Cohan VL; Hubbard WC; Kagey-Sobotka A; Lichtenstein LM
J Immunol; 1987 Nov; 139(9):3062-9. PubMed ID: 2444649
[TBL] [Abstract][Full Text] [Related]
8. Co-culture of human lung-derived mast cells with mouse 3T3 fibroblasts: morphology and IgE-mediated release of histamine, prostaglandin D2, and leukotrienes.
Levi-Schaffer F; Austen KF; Caulfield JP; Hein A; Gravallese PM; Stevens RL
J Immunol; 1987 Jul; 139(2):494-500. PubMed ID: 2439587
[TBL] [Abstract][Full Text] [Related]
9. Isoproterenol-induced inhibition of immunoglobulin E-mediated release of histamine and arachidonic acid metabolites from the human lung mast cell.
Undem BJ; Peachell PT; Lichtenstein LM
J Pharmacol Exp Ther; 1988 Oct; 247(1):209-17. PubMed ID: 2459368
[TBL] [Abstract][Full Text] [Related]
10. Generation of leukotriene C4, leukotriene B4, and prostaglandin D2 by immunologically activated rat intestinal mucosa mast cells.
Heavey DJ; Ernst PB; Stevens RL; Befus AD; Bienenstock J; Austen KF
J Immunol; 1988 Mar; 140(6):1953-7. PubMed ID: 2450136
[TBL] [Abstract][Full Text] [Related]
11. Allergy or inflammation? From neuropeptide stimulation of human skin mast cells to studies on the mechanism of the late asthmatic response.
Church MK; Benyon RC; Lowman MA; Hutson PA; Holgate ST
Agents Actions; 1989 Jan; 26(1-2):22-30. PubMed ID: 2653005
[TBL] [Abstract][Full Text] [Related]
12. Human mast cell heterogeneity: histamine release from mast cells dispersed from skin, lung, adenoids, tonsils, and colon in response to IgE-dependent and nonimmunologic stimuli.
Lowman MA; Rees PH; Benyon RC; Church MK
J Allergy Clin Immunol; 1988 Mar; 81(3):590-7. PubMed ID: 2450114
[TBL] [Abstract][Full Text] [Related]
13. Human uterine mast cells. Isolation, purification, characterization, ultrastructure, and pharmacology.
Massey WA; Guo CB; Dvorak AM; Hubbard WC; Bhagavan BS; Cohan VL; Warner JA; Kagey-Sobotka A; Lichtenstein LM
J Immunol; 1991 Sep; 147(5):1621-7. PubMed ID: 1715365
[TBL] [Abstract][Full Text] [Related]
14. In vitro effects of H1-antihistamines on histamine and PGD2 release from mast cells of human lung, tonsil, and skin.
Okayama Y; Benyon RC; Lowman MA; Church MK
Allergy; 1994 Apr; 49(4):246-53. PubMed ID: 7518654
[TBL] [Abstract][Full Text] [Related]
15. Complement peptides C3a- and C5a-induced mediator release from dissociated human skin mast cells.
el-Lati SG; Dahinden CA; Church MK
J Invest Dermatol; 1994 May; 102(5):803-6. PubMed ID: 7513741
[TBL] [Abstract][Full Text] [Related]
16. Mast cell mediators prostaglandin-D2 and histamine activate human eosinophils.
Raible DG; Schulman ES; DiMuzio J; Cardillo R; Post TJ
J Immunol; 1992 Jun; 148(11):3536-42. PubMed ID: 1588043
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptide-induced secretion from human skin mast cells.
Church MK; el-Lati S; Caulfield JP
Int Arch Allergy Appl Immunol; 1991; 94(1-4):310-8. PubMed ID: 1718893
[TBL] [Abstract][Full Text] [Related]
18. Pituitary adenylate cyclase activating polypeptide (PACAP) is localized in human dermal neurons and causes histamine release from skin mast cells.
Odum L; Petersen LJ; Skov PS; Ebskov LB
Inflamm Res; 1998 Dec; 47(12):488-92. PubMed ID: 9892043
[TBL] [Abstract][Full Text] [Related]
19. Dexamethasone does not inhibit the release of mediators from human mast cells residing in airway, intestine, or skin.
Cohan VL; Undem BJ; Fox CC; Adkinson NF; Lichtenstein LM; Schleimer RP
Am Rev Respir Dis; 1989 Oct; 140(4):951-4. PubMed ID: 2478059
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory effect of cyclosporin A on human skin mast cells.
Stellato C; de Paulis A; Ciccarelli A; Cirillo R; Patella V; Casolaro V; Marone G
J Invest Dermatol; 1992 May; 98(5):800-4. PubMed ID: 1373749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
